Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a ...
(Nasdaq: VIR) today announced the appointment of Aziz Sawaf, MBEE, MBA, CFA, as Executive Vice President and Chief Financial ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today announced that Board member ...
Fintel reports that on September 29, 2026, Roth Capital initiated coverage of Nautilus Biotechnology (NASDAQCM:NAUT) with a Buy recommendation. On the day of the coverage initiation, September 29, ...
Duchenne muscular dystrophy is a severe, progressive, X-linked neuromuscular disease affecting approximately one in 5,000 male births. It is caused by mutations in the DMD gene that prevent the ...
Moderna's 177% stock surge followed its mRNA cancer vaccine success, but CEO Stéphane Bancel says China's biotechnology investments pose a threat.
At Houston City College (HCC), leaders are working closely with industry partners to ensure the region's workforce pipeline ...
Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results